2,4-dinitrobenzenesulfonic acid has been researched along with iodoacetamide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brazowski, E; Dotan, I; Halpern, Z; Hershkoviz, R; Karmeli, F; Peled, Y; Rachmilewitz, D | 1 |
| Brigidi, P; Campieri, M; Eliakim, R; Gionchetti, P; Karmeli, F; Morgenstern, S; Rachmilewitz, D; Shibolet, O; Swennen, E | 1 |
2 other study(ies) available for 2,4-dinitrobenzenesulfonic acid and iodoacetamide
| Article | Year |
|---|---|
Heparin and low-molecular-weight heparin (enoxaparin) significantly ameliorate experimental colitis in rats.
Topics: Animals; Anti-Inflammatory Agents; Anticoagulants; Benzenesulfonates; Colitis; Disease Models, Animal; Dose-Response Relationship, Drug; Enoxaparin; Heparin; Iodoacetamide; Male; Nitric Oxide Synthase; Peroxidase; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha | 2001 |
Variable response to probiotics in two models of experimental colitis in rats.
Topics: Alkylating Agents; Animals; Benzenesulfonates; Bifidobacterium; Colitis; Disease Models, Animal; Intestinal Mucosa; Iodoacetamide; Lactobacillus; Male; Probiotics; Rats; Rats, Sprague-Dawley; Streptococcus | 2002 |